CSI Market
Sign In | Register

Mallinckrodt Plc (MNKKQ) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access MNKKQ quarterly Cash Flow →
Tracking cash flow results across Mallinckrodt Plc to Dec 28 2018 helps illustrate how Dec 27 2024's cash generation has responded to changing business conditions.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 27 2024)
12 Months 		(Dec 31 2021) (Dec 25 2020) (Dec 27 2019) (Dec 28 2018)
Operating Activities
Income476.60
Depreciation & amortization73.60
Amortization of Other Assets66.20
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Asset Impairment Charges2.80
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories-202.40
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Business754.40
Share-based Compensation25.70
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction-19.70
Income taxes136.70
Losses/ -gains on Investments net17.40
Increase (Decrease) in Accounts Receivable-1.20
Increase (Decrease) in Accounts Payable-8.60
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Prepaid Expense and Other Assets0.00
Other Working Capital0.50
Other Noncash Income (Expense)-4.20
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations342.30
Net Cash flow from Operating Activities-48.00
Investing Activities
Capital Expenditures-54.80
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)22.60
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Proceeds from Divestiture of Businesses, Net of Cash Divested876.20
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities3.70
Other Net12.00
Discontinued operations-34.60
Net Cash Flow from Investing Activities825.10
Financing Activities
Short-term debt Net0.00
Other borrowing transactions-63.70
Long-term debt - borrowings-782.10
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net-0.60
Other net0.00
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-846.40
Effect of exchange rate on cash flow0.00
Discontinued operations174.10
Free Cash Flow-102.80
Total Cash Flow102.30
4 historic quarters locked

Sign in to unlock the full Mallinckrodt Plc cash flow history.

Sign In Create Free Account

About Keenova Therapeutics Plc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: April 15, 2026
  • Source: mnk-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001628280-26-025238

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License